Business context and reporting period
The filing is Security Devices International, Inc. (SDI), a development-stage non-lethal defense technology company—not Byrna Technologies Inc. The unaudited Form 10-Q covers the quarter and nine months ended August 31, 2012. SDI was developing 40mm blunt-impact and wireless-electric projectiles and reported no revenue from inception through the period.
Financial results and position
| Metric | Three months ended August 31, 2012 | Nine months ended August 31, 2012 |
|---|---|---|
| Revenue | No revenue reported | No revenue reported |
| Operating expenses | $313,096 | $824,559 |
| Interest expense | $37,534 | $126,711 |
| Net loss | $350,630 | $951,270 |
| Loss per share, basic and diluted | $0.01 | $0.04 |
| Operating cash used | Not stated by quarter | $881,786 |
At August 31, 2012, cash was $395,830; current assets were $405,142; current liabilities were $322,712; total liabilities were $1,511,466, including $1,335,254 of convertible debentures; and stockholders’ deficit was $952,518. Working capital was $82,430. The company reported no meaningful revenue-based margins.
Material changes versus comparable periods
- Quarterly net loss increased to $350,630 from $205,180 in 2011; nine-month net loss increased to $951,270 from $697,811. Management attributed the quarterly increase mainly to higher consulting and management fees and $75,013 of warrant compensation expense.
- Cash increased from $114,835 at November 30, 2011 to $395,830 at August 31, 2012. Nine-month financing provided $1,310,000, while operating and investing activities used $881,786 and $147,219, respectively.
- Current liabilities declined from $704,993 to $322,712, primarily reflecting settlement of the Elad payable. SDI paid Elad $100,000 to settle a $315,143 payable and recorded a $215,143 recovery of development costs.
- Plant and equipment rose to $153,806 from $18,414, including $142,140 of molds. Common shares outstanding increased to 29,645,552, including shares issued for $400,000 cash and conversion of $445,251 of debt and accrued interest.
Outlook, risks and unusual items
- Management estimated $1,750,000 of capital needs for the 12 months through August 31, 2013: $275,000 for development and production and $1,475,000 for general and administrative costs. No additional capital commitments were in place.
- The filing states that SDI has no operating cash flows, has accumulated losses of $18,227,478, expects further losses, and needs additional working capital. Management concluded these conditions raise substantial doubt about the company’s ability to continue as a going concern; future financing is not assured.
- SDI reported third-party human-effects testing and shipping-safety testing for its BIP munitions, and continued development of product variants. These are development and commercialization milestones, not reported sales or revenue.
- Convertible debentures included overdue $100,000 and $46,500 instruments whose principal remained unpaid at maturity, and newer debt with conversion features and default provisions. The filing describes related-party consulting payments and option/warrant awards; total nine-month stock-based compensation was $288,453.
- After quarter-end, the board approved a conditional exchange of 905,000 options for an equal number of warrants. The filing cites risks including financing availability, product acceptance and liability, regulation, suppliers, distribution, competition, intellectual property, currency exposure, and thin OTC trading.
Key facts investors should verify
- Confirm the issuer identity: the supplied filing names Security Devices International, Inc., although the request metadata names Byrna Technologies Inc.
- Verify the maturity dates and status of the debentures: the filing contains apparent date inconsistencies for certain 2012 debentures, while reporting the $146,500 current portion and unpaid matured debt.
- Assess whether the $1.75 million estimated capital requirement can be funded and how long the reported cash balance can support operations.
- Track whether testing, manufacturing partnerships, regulatory/shipping steps, and distribution plans lead to product launches and actual revenue.
- Review dilution and related-party terms, including convertible debt, warrants/options, and the 29,645,552 shares outstanding as of September 10, 2012.